BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 31548505)

  • 1. Ovarian Follicle Depletion Induced by Chemotherapy and the Investigational Stages of Potential Fertility-Protective Treatments-A Review.
    Hao X; Anastácio A; Liu K; Rodriguez-Wallberg KA
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31548505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian damage from chemotherapy and current approaches to its protection.
    Spears N; Lopes F; Stefansdottir A; Rossi V; De Felici M; Anderson RA; Klinger FG
    Hum Reprod Update; 2019 Nov; 25(6):673-693. PubMed ID: 31600388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-induced ovarian damage and protective strategies.
    Zhao P; Guo C; Du H; Xiao Y; Su J; Wang X; Yeung WSB; Li G; Wang T
    Hum Fertil (Camb); 2023 Oct; 26(4):887-900. PubMed ID: 38054300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy-induced damage to ovary: mechanisms and clinical impact.
    Bedoschi G; Navarro PA; Oktay K
    Future Oncol; 2016 Oct; 12(20):2333-44. PubMed ID: 27402553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of chemotherapy-induced ovarian damage.
    Roness H; Kashi O; Meirow D
    Fertil Steril; 2016 Jan; 105(1):20-9. PubMed ID: 26677788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling the mechanisms of chemotherapy-induced damage to human primordial follicle reserve: road to developing therapeutics for fertility preservation and reversing ovarian aging.
    Szymanska KJ; Tan X; Oktay K
    Mol Hum Reprod; 2020 Aug; 26(8):553-566. PubMed ID: 32514568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overactivation or Apoptosis: Which Mechanisms Affect Chemotherapy-Induced Ovarian Reserve Depletion?
    Kashi O; Meirow D
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agents.
    Roness H; Kalich-Philosoph L; Meirow D
    Hum Reprod Update; 2014; 20(5):759-74. PubMed ID: 24833728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin provides protection against cisplatin-induced ovarian damage and loss of fertility in mice.
    Huang J; Shan W; Li N; Zhou B; Guo E; Xia M; Lu H; Wu Y; Chen J; Wang B; Xi L; Ma D; Chen G; Li K; Sun C
    Reprod Biomed Online; 2021 Mar; 42(3):505-519. PubMed ID: 33388265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can Some Anticancer Treatments Preserve the Ovarian Reserve?
    Vallet N; Boissel N; Elefant E; Chevillon F; Pasquer H; Calvo C; Dhedin N; Poirot C
    Oncologist; 2021 Jun; 26(6):492-503. PubMed ID: 33458904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vincristine Chemotherapy Induces Atresia of Growing Ovarian Follicles in Mice.
    Winship AL; Carpenter M; Griffiths M; Hutt KJ
    Toxicol Sci; 2019 May; 169(1):43-53. PubMed ID: 30657998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidose 5-Fluorouracil is Highly Toxic to Growing Ovarian Follicles in Mice.
    Stringer JM; Swindells EOK; Zerafa N; Liew SH; Hutt KJ
    Toxicol Sci; 2018 Nov; 166(1):97-107. PubMed ID: 30085306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both in vivo FSH depletion and follicular exposure to Gonadotrophin-releasing hormone analogues in vitro are not effective to prevent follicular depletion during chemotherapy in mice.
    Horicks F; Van Den Steen G; Gervy C; Clarke HJ; Demeestere I
    Mol Hum Reprod; 2018 Apr; 24(4):221-232. PubMed ID: 29438534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice.
    Sonigo C; Beau I; Grynberg M; Binart N
    FASEB J; 2019 Jan; 33(1):1278-1287. PubMed ID: 30113879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orthotopic transplantation of cryopreserved mouse ovaries and gonadotrophin releasing hormone analogues in the restoration of function following chemotherapy-induced ovarian damage.
    Li Q; Szatmary P; Liu Y; Ding Z; Zhou J; Sun Y; Luo F; Wang Y; Zhu J
    PLoS One; 2015; 10(3):e0120736. PubMed ID: 25811681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy and fertility.
    Blumenfeld Z
    Best Pract Res Clin Obstet Gynaecol; 2012 Jun; 26(3):379-90. PubMed ID: 22281514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A gonadotropin-releasing hormone agonist for the prevention of docetaxel-induced gonadal damage.
    Park I; Lee S; Ryu KJ; Min KJ; Hong JH; Song JY; Lee JK; Lee NW
    J Obstet Gynaecol; 2017 Aug; 37(6):783-789. PubMed ID: 28502234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy.
    Goldman KN; Chenette D; Arju R; Duncan FE; Keefe DL; Grifo JA; Schneider RJ
    Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3186-3191. PubMed ID: 28270607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency.
    Suzuki N; Yoshioka N; Takae S; Sugishita Y; Tamura M; Hashimoto S; Morimoto Y; Kawamura K
    Hum Reprod; 2015 Mar; 30(3):608-15. PubMed ID: 25567618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure.
    Pascuali N; Scotti L; Di Pietro M; Oubiña G; Bas D; May M; Gómez Muñoz A; Cuasnicú PS; Cohen DJ; Tesone M; Abramovich D; Parborell F
    Hum Reprod; 2018 May; 33(5):844-859. PubMed ID: 29534229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.